EVOK icon

Evoke Pharma
EVOK

Overview Fund Trends Analyst Outlook Journalist POV

18 hedge funds and large institutions have $1.27M invested in Evoke Pharma in 2019 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more ownership

Funds ownership: →

less funds holding

Funds holding: →

20% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 5

Holders
18
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$222K
2
+$79K
3
+$32K
4
Jane Street
Jane Street
New York
+$11K
5
CAN
Cetera Advisor Networks
California
+$9K

Top Sellers

1
-$67K
2
-$37K
3
-$13K
4
Morgan Stanley
Morgan Stanley
New York
-$5.3K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$4.39K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$415K
2
$344K
3
$171K
4
$86K
5
$47K
6
$32K
7
$32K
8
$29K
9
$29K
10
$27K
11
$25K
12
$13K
13
$11K
14
$9K
15
$3K
16
$1K
17
$1K
18
–
19
–
20
–
21
–
22
–